Cell Culture Market 2018 Analysis, Key Players, Size, Growth Rate and Forecasts to 2023

1. MarketsandMarkets Presents Cell Culture Market by Consumables (Serum free media, FBS, ABS), Equipment {Bioreactor, Supporting Equipment (Centrifuge, Filtration System)}, Application (Biopharmaceutical, Cancer Research), End Users (Pharma, Research) - Global Forecast to 2023 https://www.marketsandmarkets.com/Market-Reports/cell-culture-market-media-sera-reagents-559.html

2. According to a new market research report "Cell Culture Marketby Consumables (Serum free media, FBS, ABS), Equipment {Bioreactor, Supporting Equipment (Centrifuge, Filtration System), Application (Biopharmaceutical, Cancer Research), End Users (Pharma, Research) - Global Forecast to 2023", published by MarketsandMarkets™, the market is expected to reach USD 26.28 Billion by 2023 from USD 15.32 Billion in 2018, at a CAGR of 11.4%.  Browse 258 market data Tables and36 Figures spread through247 Pages and in-depth TOC on"Cell Culture Market" Get The PDF Brochure For This Report: https://www.marketsandmarkets.com/pdfdownload.asp?id=559 The global antinuclear antibody test market is expected to reach USD 1,476.1 Million by 2021 from USD 823.5 Million in 2016, at a CAGR of 12.4% from 2016 to 2021.

3. Scope of the Report: • This report categorizes the antinuclear antibody test market into the following segments: • Cell Culture Market, by Product • EquipmentBioreactors • Conventional Bioreactors • Single-Use Bioreactors • Cell Culture Market, by Application • Biopharmaceutical/Therapeutics •  Vaccine Production • Diagnostics • Cell Culture Market, by End User • Pharmaceutical and Biotechnology Companies • Research Institutes •  Request Sample of the report: • https://www.marketsandmarkets.com/requestsample.asp?id=559

4. Industry Insights: Based on application, the cell culture market is segmented into biopharmaceutical/therapeutic, stem cell technologies, drug screening and development, tissue engineering and regenerative medicine, cancer research, and other applications. The biopharmaceuticals/therapeutic applications segment is expected to register the highest CAGR during the forecast period. The high growth of this segment is attributed to the commercial expansion of major pharmaceutical companies, growing regulatory approvals for the production of cell culture-based vaccines, and increase in the demand for monoclonal antibodies (mAbs). Based on end user, the cell culture market is segmented into pharmaceutical and biotechnology companies and research institutes. The pharmaceutical and biotechnology companies segment accounted for the largest market share in 2017 and it is projected to register the highest CAGR during the forecast period. The growing use of single-use technologies, increasing number of regulatory approvals for cell culture-based vaccines, and presence of a large number of pharmaceutical players in this market are driving the global market for this end-user segment. https://www.marketsandmarkets.com/Market-Reports/cell-culture-market-media-sera-reagents-559.html

5. Industry Leaders: The cell culture market is fragmented with the presence of several large as well as emerging players. In 2017, Thermo Fisher Scientific (US), Merck KGaA (Germany), and GE Healthcare (US) were the leading players in the global market. Other major players include Lonza (Switzerland), Becton, Dickinson and Company (US), Corning Incorporated (US), Eppendorf (Germany), HiMedia Laboratories (India), Sartorius AG (Germany), PromoCell GmbH (Germany), Pall Corporation (acquired by Danaher (US)), Irvine Scientific (US), InvivoGen (US), and CellGenix GmbH (Germany). https://www.marketsandmarkets.com/Market-Reports/cell-culture-market-media-sera-reagents-559.html

6. About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.  http://www.marketsandmarkets.com/Market-Reports/antinuclear-antibody-test-market-218189007.html

7. Contact Us Mr. Rohan MarketsandMarkets™ 701 Pike Street Suite 2175, Seattle, WA 98101, United States Tel: 1-888-600-6441 Email: sales@marketsandmarkets.comMarketsandMarkets Bloghttp://www.marketsandmarkets.comhttp://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets